Metabolic syndrome is a predictor for an ECG sign of no-reflow after primary PCI in patients with acute ST-elevation myocardial infarction


TARTAN Z., OZER N., UYAREL H., AKGUL O., GUL M., Cetin M. , ...Daha Fazla

NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, cilt.18, sa.6, ss.441-447, 2008 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 18 Konu: 6
  • Basım Tarihi: 2008
  • Doi Numarası: 10.1016/j.numecd.2007.02.015
  • Dergi Adı: NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
  • Sayfa Sayıları: ss.441-447

Özet

background and aim: The purpose of this study was to evaluate both the predictive value of metabolic syndrome (MS) on no-reflow phenomenon and 30-day clinical outcomes on patients undergoing primary percutaneous coronary intervention (PCI) for acute ST-elevation myocardial infaction (STEMI).